Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahsa Abassi

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Open Forum Infectious Diseases|July 26, 2024
Mid-Upper Arm Circumference Is a Strong Predictor of Mortality Among Ugandan Adults With HIV-Associated Cryptococcal Meningitis: A Prospective Cohort StudyGila Hale, Tessa Adzemovic, Kathy Huppler Hullsiek, et al.
The Lancet. Infectious Diseases|March 14, 2016
Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging studyJoshua Rhein, Bozena M Morawski, Kathy Huppler Hullsiek, et al.
Open Forum Infectious Diseases|July 27, 2022
Association of Hyponatremia on Mortality in Cryptococcal Meningitis: A Prospective CohortLillian Tugume, Ann Fieberg, Kenneth Ssebambulidde, et al.
Open Forum Infectious Diseases|May 5, 2020
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)Katelyn A Pastick, Elizabeth C Okafor, Fan Wang, et al.
Open Forum Infectious Diseases|February 12, 2020
Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and OutcomesKatelyn A Pastick, Ananta S Bangdiwala, Mahsa Abassi, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Utility of Cerebrospinal Fluid Protein Levels as a Potential Predictive Biomarker of Disease Severity in HIV-Associated Cryptococcal MeningitisJohn Kasibante, Eesha Irfanullah, Abduljewad Wele, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2022
Recurrence of Symptoms Following Cryptococcal Meningitis: Characterizing a Diagnostic Conundrum With Multiple EtiologiesNathan C Bahr, Caleb P Skipper, Kathy Huppler-Hullsiek, et al.
Plos One|January 6, 2018
Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detectionEdward Mpoza, Liliane Mukaremera, Didas Atwebembere Kundura, et al.
Medical Mycology|October 17, 2024
Clinical importance of cerebrospinal fluid protein levels in HIV-associated cryptococcal meningitis: Insights from a prospective cohort study in UgandaJohn Kasibante, Eesha Irfanullah, Abduljewad Wele, et al.
The Journal of Infectious Diseases|March 23, 2017
Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal MeningitisSarah Lofgren, Kathy H Hullsiek, Bozena M Morawski, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Open Forum Infectious Diseases|July 26, 2024
Mid-Upper Arm Circumference Is a Strong Predictor of Mortality Among Ugandan Adults With HIV-Associated Cryptococcal Meningitis: A Prospective Cohort StudyGila Hale, Tessa Adzemovic, Kathy Huppler Hullsiek, et al.
The Lancet. Infectious Diseases|March 14, 2016
Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging studyJoshua Rhein, Bozena M Morawski, Kathy Huppler Hullsiek, et al.
Open Forum Infectious Diseases|July 27, 2022
Association of Hyponatremia on Mortality in Cryptococcal Meningitis: A Prospective CohortLillian Tugume, Ann Fieberg, Kenneth Ssebambulidde, et al.
Open Forum Infectious Diseases|May 5, 2020
Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19)Katelyn A Pastick, Elizabeth C Okafor, Fan Wang, et al.
Open Forum Infectious Diseases|February 12, 2020
Seizures in Human Immunodeficiency Virus-Associated Cryptococcal Meningitis: Predictors and OutcomesKatelyn A Pastick, Ananta S Bangdiwala, Mahsa Abassi, et al.
Medrxiv : the Preprint Server for Health Sciences|January 3, 2024
Utility of Cerebrospinal Fluid Protein Levels as a Potential Predictive Biomarker of Disease Severity in HIV-Associated Cryptococcal MeningitisJohn Kasibante, Eesha Irfanullah, Abduljewad Wele, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 28, 2022
Recurrence of Symptoms Following Cryptococcal Meningitis: Characterizing a Diagnostic Conundrum With Multiple EtiologiesNathan C Bahr, Caleb P Skipper, Kathy Huppler-Hullsiek, et al.
Plos One|January 6, 2018
Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detectionEdward Mpoza, Liliane Mukaremera, Didas Atwebembere Kundura, et al.
Medical Mycology|October 17, 2024
Clinical importance of cerebrospinal fluid protein levels in HIV-associated cryptococcal meningitis: Insights from a prospective cohort study in UgandaJohn Kasibante, Eesha Irfanullah, Abduljewad Wele, et al.
The Journal of Infectious Diseases|March 23, 2017
Differences in Immunologic Factors Among Patients Presenting with Altered Mental Status During Cryptococcal MeningitisSarah Lofgren, Kathy H Hullsiek, Bozena M Morawski, et al.
Pageof 6